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f^eurobehavioral Symptoms in Mild Primary Hyperparathyroidism:
Related to Hypercalcemia but not Improved by Parathyroidectomy
Gregory G. Brown, PhD,* Richard C. Preisman, MD,* and Michael Kleerekoper, MD^

The neurobehavioral symptomatology of severe primary hyperparathyroidism (PHPT) has been
thoroughly described. Less is known about more mild cases. We evaluated 34 patients with mild PHPT
and followed 19 for an average of six months. Of those cases followed, ten had parathyroidectomy
(PTX). Patients with no neurobehavioral abnormalities had the lowest serum calcium levels (10.9 ±
0.88 mg/dL), patients with signs of affective disorder had intermediate levels (11.25 ± 0.66 mg/dL),
and patients with signs of cerebral dysfunction had the highest levels (12.17 ± 1.17 mg/dL). Serum
calcium significantly correlated with motor speed, psychomotor speed, fluid intelligence, and shortterm memory. However, in the follow-up ofpatients, PTX seemed to have no effect on their behavior
Serum calcium correlates with both type and severity ofthe neurobehavioral abnormalities found in
mild PHPT. However, most of the evidence indicates that PTX does not produce any improvement of
these abnormalities, even when the hypercalcemia elevation is corrected. (Henry Ford Hosp MedJ
1987:35:211-5)

variety of neurobehavioral symptoms have been associated
with primary hyperparathyroidism (PHPT) since Nielsen
drew attention to this phenomenon in the mid 1930s and early
neoplasms and I
1940s (1,2). Lethargy, drowsiness, depressive mood, neurasthenia, paranoid delusions, hallucinations, disorientation, conparathyroidism
fusion, and memory deficits all have been reported in a series
of case studies (3-8). However, group studies have not always
found a greater occunence of psychiatric symptoms in PHPT
than would be expected among medically ill patients in general (9-20). As shown in the Table, prevalence rates from caseseries studies range from 1% to 65%. The validity of many of
these rates is difficult to evaluate, since most investigators obtained data through retrospective chart review, did not state how
patients were sampled, or failed to describe the method used to
investigate the presence of psychiatric symptoms. Only two
studies (12,20) reported their methods in sufficient detail to enable us to determine that a consecutive series was examined, and
only three studies (17,18,20) described their method of psychiatric evaluation.

A

With the advent of routine biochemical screening, a dramatic
increase has occuned in the detection of cases of hypercalcemia
with few or no other symptoms of PHPT (21). Many patients
presenting with mild hypercalcemia have neurobehavioral complaints as their only symptoms. Whether surgical conection of
PHPT is indicated in these patients is a question that the aforementioned literature does not convincingly answer Several
authors have claimed that mental changes may occur at mild
calcium elevations and clear with parathyroidectomy (PTX)
(22-24). These authors at least implicitly endorse surgery
for
conection of these mental changes, even at mild levels of
hypercalcemia.
Questions even more fundamental than response to PTX are
still in need of research: How often do neurobehavioral abnor-
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malities occur in PHPT? What variations occur intiiesesymptoms? What is the relationship between these neurobehavioral
abnormalities and semm calcium?
In this paper we present our findings on a group of patients with PHPT in whom neurobehavioral assessment was performed shortly after the diagnosis had been made and again
after successful PTX or after medical follow-up, if surgery was
not performed.

Methods
Subjects
Thirty-four patients with no previous history of parathyroid
disease were evaluated over a 30-month period. These cases, refened for neurobehavioral assessment from the Bone & Mineral
Division, represented siightiy more than half of the PHPT cases
seen in the clinic during this period. Not all of the physicians in
the Bone & Mineral Division were enrolling patients when the
study began. Any bias introduced into the sample studied was
due to differences in the practices of the physicians who refened
patients and those who did not. All patients who were refened to
the study, 23 women and I I men, were evaluated. Their mean
age was 52.5 ± 12.3 years (mean ± standard deviation), and on
the average they had high school educations (12.0 ± 2.7 years).
Patients were excluded from the study if they had a history of
substance abuse, secondary hyperparathyroidism, or coincidental neurological diagnosis. As a group, these patients had mild
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Table
Case Series Studies of Psychiatric Symptoms in Hyperparathyroidism
Authors
Eitinger(1942) (9)
St. Goar(1957)(10)
Cope(1960)(14)
Hellstt-om & Ivermark (1962) (11)
Karpati& Frame (1964) (12)

Number of
Cases
.SO
45
230
138
.^3

Neuropsychiatric
Symptoms, n(%)
7(14)
3(7)
2(1)
11 (8)
14 (42)

Henson(1966)(13)

34

8(24)

Watson (1968) (15)

200

8 (4)

Anderson* (1968) (16)

30

Petersen (1968) (17)

54

3 (10)
7 (23)
36 (65)

Mallette etal (1974) (18)

51

19 (33)

Palmer (1983) (19)

IIO

25 (23)

Jobom etal (1986) (20)

441

102 (23)

Types of Symptoms
"Psychic changes"
"Pronounced emotional symptoms"
"Mental disturbance"
Nervous disorders; depression
Anxiety, tension, irritability,
depression, confusional state
Depression, anxiety, loss of energy,
paranoia
"Mental symptoms"; "psychological
disorders"
Depression, loss of energy, thought
disorder, paranoia, disoriented
Impairment of memory, neurasthenic
personality changes, affective disturbance, acute organic psychosis
with disorientation, delerium, confusion, paranoid ideas
Decreased memory for recent events,
irritability, depression, one case
psychotic, one case delirious
Poor memory, anxiety, depression,
hysterical personality, organic
brain syndrome
Depression, anxiety, psychosis,
organic brain syndrome, minor
cerebral impairment

•Regarding neuropsychiatric symptoms, the first entry is the number of patients who presented as psychotic, and the second
entry is the number of patients who gave a history of depression and loss of energy.

PHPT with a mean calcium of 11.5 ± 1.05 mg/dL. Of the entire
sample, 21% had no physical symptoms directly refenable to
hyperthyroidism or hypercalcemia; only 10% had renal stones,
and another 7% had peptic ulcers. The remaining patients had
incidental medical diseases, of which hypertension was the most
common. In general, patients with a semm calcium level greater
than 11.5 mg/dL were refened for elective surgery, but this procedure was not always followed, and not all patients refened for
surgery agreed to proceed.
Procedures
To evaluate personality functioning and mental status, each
patient received a battery of neuropsychological tests and/or
a psychiatric interview; seven had psychological testing alone,
while three had the interview alone. Differences in how the
patients were evaluated were due to the temporary unavailability of the neuropsychologist or psychiatrist for inpatients with brief hospitalizations. The brief neuropsychological
battery assessed amnestic, intellectual, motor, psychomotor,
and personality functioning. The battery was composed of the
Similarities, Block Design, and Digit Symbol subtests from the
Wechsler Adult Intelligence Scale (25), the Trail Making Test
(26), the Short-Term Memory (STM) Distractor Test (27),
Halstead's Finger Oscillation Test (28), and the Minnesota Multiphasic Personality Inventory (MMPI) (29). The mean of the
three IQ subtests was used in the data analysis. These IQ subtests primarily measure the effects of fluid intelligence, which
involves intellectual abilities necessary for the rapid solving of
novel problems. The Trail Making Test is a general indicator of
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cerebral dysfunction, taken from the Halstead-Reitan Neuropsychology Battery. Adequate performance on this test presumes normal visual scanning, concentration, and psychomotor
speed. The version of the STM Distractor Test that we used required subjects to remember a word during a 10- or 20-second
period of subtracting backwards by threes from a three-digit
number Patients were also tested after a no-delay interval, but
only the average of the 10- and 20-second conditions was used in
the data analysis. The STM Distractor Test has been shown to be
sensitive to memory deficits in patients with classical amnesias
(eg, bilateral hippocampectomy, or alcoholic Korsakoff amnesia) (30). The psychiatric interview included an assessment of
orientation, immediate memory, verbal reasoning, andconstmctional ability, in addition to an evaluation of thinking style>
delusions, affect, mood, and hallucinations. The patient's history and medical record were used to estimate the duration of
neurobehavioral symptoms.

Results
Group studies
Initialfindings—Toextend the analysis to patients who had
either a psychiatric interview or a neuropsychological evalu^'
tion, but not both, we examined the degree of concordance between the two methods for classifying patients into three groups1) no behavioral disorders, 2) affective disorders, and 3) neU'
robehavioral signs of brain dysfunction. Independent judgme"'^
of each patient's classification revealed an 82% agreement (K "
0.73) between the psychiatric interview and neuropsychologK^
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^valuation. We reconciled the few differences between the two
jjiethods and then classified the remaining cases.
Only 29% of our sample were clearly normal in their neurobehavioral function; 32% had signs of affective disorder, while
39% had signs of cerebral dysfunction. Included in this latter group was a small number of patients who displayed paranoid
features in addition to cognitive abnormalities. Comparisons of
the semm calcium for the three groups indicated a significant
difference, F(2,28) = 4.86, P < 0.05. Planned comparisons
ijidicated that the group judged to be normal had lower mean calcium levels (10.9 ± 0.88 mg/dL) than the other two groups
combined, t(28) = -2.15, P < 0.05. An additional planned
comparison indicated that the patients with affective disorders
had a lower mean calcium (11.25 ± 0.66 mg/dL) than patients
with signs of brain dysfunction (12.17 ± 1.17 mg/dL), f(28) =
2.32, P < 0.05.
These analyses suggest that qualitative differences in neurobehavioral dysfunction occuned as a consequence of increasing calcium levels. Subsequent analyses showed that the intensity of neurobehavioral impairment, as measured by tests of
motor speed, psychomotor speed, intelligence, and short-term
memory, was also correlated with serum calcium. The conelations were; -0.33, P < 0.05, for the mean tapping score
averaged over the two hands; - 0.45, P < 0.01, for fluid intelligence; -0.36, P < 0.05, for STM; and 0.39, P < 0.05, for
the Trail Making Test. The direction of all four conelations indicated that poorer performance was associated with higher calcium levels. Only the depression scale of the MMPI failed to
significantiy conelate with semm calcium.
Effects of PTX—Nineteen patients had repeat testing of neurobehavioral function. Ten patients had testing repeated approximately six months after successful PTX (mean preoperative
serum calcium was 11.7 ± 1.0 mg/dL, and mean semm calcium
at follow-up was 9.2 ± 0.94 mg/dL). Repeat testing was performed in the remaining nine patients six months after the initial
evaluation (mean serum calcium at initial testing was 11.0 ±
0.98 mg/dL, and mean semm calcium at follow-up was 10.7 ±
0.82 mg/dL). A significant difference occuned in the amount of
change in semm calcium between the surgical and nonsurgical
groups, F(l,16) = 7.63, P < 0.01, with the nonsurgical group
displaying no significant reduction in serum calcium. While
PTX lowered semm calcium, nonsurgical treatment did not.
At the initial evaluation, the surgical and nonsurgical groups
did not differ regarding age, education, sex, and semm calcium.
The two groups did not differ on the interval between the two
evaluations. Despite the significant reduction in the semm calcium following PTX, we observed no differential improvement
in functioning for those behavioral domains that were conelated
with the semm calcium at the initial testing.

Case Reports
Serum calcium was associated with type and severity of neurohfihavioral dysfunction. However, the modest size of the correlations
^nggested that factors other than calcium contributed to a patient's be'•avioral condition. The following cases are examples of patients whose
Psychopathology was long-standing. PTX had little effect on the long^•te outcome of their behavioral disorder
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Casel
A 49-year-old woman underwent surgery for an adenoma; her calcium level nearest the interview was 11.4 mg/dL. Her history suggested
several episodes of fatigue and depression throughout her adult life. She
had attempted suicide by overdose nine years before surgery. Preoperative mental status examination revealed a compulsive personality
style and euthymic mood. Chart review revealed documentation of "severe anxiety" three years after surgery, and psychiatric treatment was
advised.

Case 2
A 60-year-old woman worried about "becoming crazy" after surgery. The calcium level near her interview was 11.2 mg/dL. Biopsy
diagnosed adenomata of two glands, with hyperplasia of the biopsied
remaining two glands; postoperative calcium level was normal. She
described lifelong anxiety, and the mental status examination revealed
mild dysphoria, a compulsive behavioral style, and mild anxiety. The
patient subsequentiy suffered three episodes of major depressive disorder beginning one year after surgery. Treatment with tricyclic antidepressants was successful, and she retumed to a euthymic state.

Case 3
A 73-year-old woman had moderate anxiety in her preoperative
interview. Her calcium level near the interview was 10.9 mg/dL. An
adenoma was removed during surgery, but 16 months later chart notes
revealed that the patient experienced continued fatigue with normal
calcium levels.

Case 4
The examination of a 59-year-old woman revealed paranoia, intellectual deficits, and forgetfulness. Her calcium level near the interview
was 12.5 mg/dL, and an adenoma was removed at surgery. Chart review
revealed a schizophreniform psychosis six months postsurgery with
psychiatric hospitalization. A 14-year presurgical history of recurrent
psychosis was discovered.

Discussion
As indicated in the Table, several studies address the problem
of neurobehavioral symptoms in PHPT. Most of these studies
were based on retrospective chart review, and details of the
method of evaluation were scant in several reports. These caseseries studies also varied on the amount of detail provided about
types of psychiatric symptoms. Several investigators employed
vague and general terms when describing their patients. This
vagueness not only reduces the relevance of these studies for current practice, but also raises questions about the sensitivity of
these investigations to the presence of subtie or atypical behavioral disorders. As the Table indicates, those investigators
who distinguished among various types of psychiatric symptoms uniformly reported higher rates than those who used global
terms such as "emotional symptoms" or "emotional disturbance." Many of the earlier studies in particular areflawedby
overiy diffuse analyses of psychiatric symptomatology, which
would bias them toward overiy conservative estimates of rates of
psychopathology.
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In outpatient medical settings psychiatric illness prevalence
ranges from 10% to 20% (31). The prevalence of psychological
morbidity in this study is at least 3.5 times higher than expected.
Even when allowing for different methods of investigation
among studies, the literature indicates that psychiatric morbidity
is considerably higher in PHPT than would be expected among
general medical outpatients.
The types of neurobehavioral symptoms found in this study
were similar to those reported by other investigators. We found
mild to severe affective disorder, paranoid ideation, anxiety,
lethargy, impaired motor and psychomotor speed, disorientation, impairment of memory, impaired fluid intelligence, and
constmctional dyspraxia for both drawings and block constmctions. The range of neurobehavioral syndromes seen in PHPT is
fairly well established and includes affective disorder, psychotic
symptoms, particularly paranoid ideation, and mild to severe
organic brain syndrome.
Semm calcium conelated with both the type and severity of
the neurobehavioral abnormalities observed. Affective disorders seemed to lie midway between normal functioning and
impairment of cognitive functioning, while a few of the patients who displayed signs of cognitive deficits also had paranoid delusions. Further, semm calcium formed small but significant conelations with measures of motor and psychomotor
speed, memory functioning, and fluid intelligence. Based on his
review of earlier cases and on his own work, Peterson (17) suggested that hypercalcemia between 12 and 16 mg/dL was associated with personality changes, while organic psychosis and confusional states occuned when hypercalcemia was between 16
and 19 mg/dL. Above 19 mg/dL, somnolence and coma occur
Our results and those of others, including Peterson's, suggest
that this scheme is oversimplified. Personality changes can occur below the 12 mg/dL range, while signs of organic psychosis
can appear at the 12 to 16 mg/dL range. Further, elevations above
20 mg/dL do not lead to coma and somnolence in an obligatory
manner Hanes (32) and Frame et al (33) reported on patients
who were "cheerful and uncomplaining" despite a semm calcium level of 20 mg/dL. A weak, general relationship exists
between hypercalcemia and the type and intensity of neurobehavioral dysfunction. However, individual differences play a
major role in moderating this relationship.
Although patients with signs of affective disorder tended
to have calcium elevations midway between those of the noninvolved patients and those with cognitive changes, some elements of depression in these cases were independent of calcium
levels. This independence surfaced in the failure to find a correlation between the depression scale on the MMPI and the initial calcium levels. Further, chart reviews indicated that some
patients with signs of affective disorder were depressed prior
to the diagnosis of PHPT and that several of these patients
continued to be depressed following conection of the hypercalcemia.
Depression was related to cognitive impairment, suggesting
that depression and hypercalcemia might make somewhat independent contributions to the prediction of cognitive deficits in
patients with PHPT. Whenfindingsfrom the depression scale of
the MMPI were combined with presurgical semm calcium, the
multiple conelation of this pair of variables with our remaining
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neurobehavioral tests improved considerably over the conelation with calcium alone. Thisfindingwas particularly strong for
tests of memory and psychomotor speed. The multiple conelation between calcium and depression, on the one hand, and the
Trail Making Test, on the other hand, was 0.52. The multiple
conelation with performance on the STM Distractor Test was
0.65.
As noted, in some patients emotional symptoms long predated
PHPT, raising the possibility that emotional disorder might contribute to theriskof developing PHPT. However, several studies failed
to find an increased incidence of PHPT in psychiatric populations
(34,35). SmaU increases ui calcium have been observed to occur in
the "switch" phenomena from depression to mania (36,37). Also,
lithium carbwnate-induced hyjjerparathyroidism has been reported
(38), indicating that some treatments of emotional disorders can increase theriskof PHPT.
Fluctuations in semm calcium are associated with behavioral
changes in a variety of diseases, suggesting an important role for
calcium in modulating behavior (39-41). Changes in calcium
could influence behavior through a large number of biochemical
pathways. Calcium is essential for the release of neurotransmitters and hormones. Consequently, calcium can have direct
and indirect effects on neuronal functioning. The neuronal
effects of calcium, occurring through hormonal release, are particularly varied. Over 30 neuropeptides, some with hormonelike stmcture, are known to act as neurotransmitters (42). Receptors for 1,25-dihydroxy vitamin Dj are thought to be present
in rat brain (43). The discovery of endorphins and other endogenous opiates has led to speculation about their possible role in
psychopathology (42). |3-endorphins might play a role in calcium flux and neurotransmitter release (44).
Surgery did not lead to differential improvement in cognitive
functioning. Our results agree with the negative findings of
Cogan's group (45). Numann and colleagues (46) didfindsome
improvement in memory and verbal reasoning following surgery. Although many of the neurobehavioral tests that we used
were also included in the Numann study, we used a different
approach to assess verbal memory (STM Distractor Test versus
Wechsler Memory Scale). This difference in method could be
the basis of the different results of the two studies. However,
Cogan's group, like Numann et al, used the Wechsler Memory Scale to assess memory and failed to find any significant
postoperative improvement in seven patients with PHPT
Numann and colleagues reported improvement on the Similarities subtest of the Wechsler Adult Intelligence Scale, and
the absence of such improvement in the present study is even
more difficult to understand. The failure to replicate Cogan et
al'sfindingscautions against using them to build a rationale for
performing PTX as a treatment of neurobehavioral symptoms in
mild PHPT. Treatment studies involving larger samples are
needed to determine which of the results previously mentioned
are most reliably replicated. PTX has not consistently led to ii"'
provement in behavioral functioning among patients with m''''
PHPT. However, there may be subgroups of patients whose n^f'
robehavioral symptoms could be ameliorated by PTX. Jobom
and colleagues (47) reported improvement in the cognitive iti^
tioning of eight elderly patients with an early onset of pf^
gressive dementia following PTX for treatment of their PH? '
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future research of the neurobehavioral effects of PTX should include methodologies for identifying particularly responsive
subgroups.
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